| MD | HB411 | Pass | Requiring the Maryland Department of Health to report to certain committees of the General Assembly on current opioid overdose reversal drugs and, for any current opioid overdose reversal drug approved by the federal Food and Drug Administration, whe...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 850 |
| MD | SB408 | Pass | Requiring the Maryland Department of Health to report, on or before December 1, 2024, December 1, 2025, and December 1, 2026, to the Senate Finance Committee and the House Health and Government Operations Committee on current opioid overdose reversal...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 849 |
| MD | SB751 | Pass | Requiring the Secretary of Health to present decisions for the allocations of money from the Opioid Restitution Fund to the Opioid Restitution Fund Advisory Council; requiring the Maryland Department of Health to post on the Department's website cert...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 851 |
| MD | HB980 | Pass | Requiring the Secretary of Health to present decisions for the allocations of money from the Opioid Restitution Fund to the Opioid Restitution Fund Advisory Council; requiring the Maryland Department of Health to post on the Department's website cert...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 852 |
| MD | SB1071 | Pass | Requiring hospitals to establish and maintain certain protocols and capacity related to the treatment of patients who are being treated for an opioid-related overdose or opioid-related emergency medical condition; requiring hospitals to make a referr...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 886 |
| MD | HB1155 | Pass | Requiring hospitals to establish and maintain certain protocols and capacity related to the treatment of patients who are being treated for an opioid-related overdose or opioid-related emergency medical condition; requiring hospitals to make a referr...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 885 |
| MD | HB1229 | Pass | Requiring a retailer that prepares, distributes, sells, or exposes for sale a kratom product to disclose the factual basis on which the representation is made; establishing prohibitions related to the preparation, distribution, and sale of kratom pro...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 748 |
| MD | SB1099 | Pass | Requiring the State Emergency Medical Services Board, in collaboration with the Maryland Department of Health, to develop and implement an initiative under the Public Access Automated External Defibrillator Program to require that naloxone be co-loca...
[Detail][Text][Discuss] | 2024-05-16
Approved by the Governor - Chapter 764 |
| MD | HB203 | Engross
Sine Die | Altering a certain requirement that the Governor's Office of Crime Prevention, Youth, and Victim Services annually report to the General Assembly about opioid use disorder among incarcerated individuals in local correctional facilities by repealing c...
[Detail][Text][Discuss] | 2024-03-18
To Senate Judicial Proceedings Committee |
| MD | SB497 | Intro
Sine Die | Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss] | 2024-03-04
Withdrawn by Sponsor |
| MD | HB1094 | Intro
Sine Die | Authorizing a community-based organization to establish an overdose prevention site pilot program with the approval of the Maryland Department of Health and in consultation with the local health department; requiring a program to acquire gas chromato...
[Detail][Text][Discuss] | 2024-03-04
Withdrawn by Sponsor |
| MD | HB736 | Intro
Sine Die | Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss] | 2024-02-26
Withdrawn by Sponsor |
| MD | HB1121 | Intro
Sine Die | Requiring a licensed health care provider who prescribes or dispenses an opioid or an opioid overdose reversal drug, to provide certain information to the individual receiving the prescription; and authorizing a pharmacist to comply with the requirem...
[Detail][Text][Discuss] | 2024-02-14
To House Health and Government Operations Committee |
| MD | HB1031 | Intro
Sine Die | Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders...
[Detail][Text][Discuss] | 2024-02-13
To House Judiciary Committee |
| MD | HB1245 | Intro
Sine Die | Prohibiting an individual from distributing heroin or fentanyl or chemical analogues of heroin or fentanyl without the lawful authority to do so, the use of which results in the death or serious bodily injury of another.
[Detail][Text][Discuss] | 2024-02-13
To House Judiciary Committee |
| MD | HB1268 | Intro
Sine Die | Requiring the State Board of Education, county boards of education, and institutions of higher education in the State to update certain drug addiction and prevention education programs to include information on the mitigating effects of naloxone or o...
[Detail][Text][Discuss] | 2024-02-13
To House Ways and Means Committee |
| MD | HB1380 | Intro
Sine Die | Requiring the Calvert County Board of Education to collect and update the data required for the federal Civil Rights Data Collection survey each year, collect certain other incident data from each public school and each school bus in the county, and ...
[Detail][Text][Discuss] | 2024-02-13
To House Ways and Means Committee |
| MD | SB1075 | Intro
Sine Die | Prohibiting an individual from distributing heroin or fentanyl or chemical analogues of heroin or fentanyl, the use of which results in the death or serious bodily injury of another.
[Detail][Text][Discuss] | 2024-02-07
To Senate Judicial Proceedings Committee |
| MD | HB519 | Intro
Sine Die | Requiring the St. Mary's County Board of Education to collect and update the data required for the federal Civil Rights Data Collection survey each year, collect certain other incident data from each public school and each school bus in the county, a...
[Detail][Text][Discuss] | 2024-02-06
To House Ways and Means Committee |
| MD | HB797 | Intro
Sine Die | Prohibiting a person, with the intent to promote a certain crime or with the intent to conceal or disguise the nature, location, source, ownership, or control of proceeds of a certain crime, from taking certain actions with respect to the proceeds de...
[Detail][Text][Discuss] | 2024-02-06
To House Judiciary Committee |
| MD | SB801 | Intro
Sine Die | Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders...
[Detail][Text][Discuss] | 2024-02-06
To Senate Budget and Taxation Committee |
| MD | SB282 | Intro
Sine Die | Altering a certain requirement that the Governor's Office of Crime Prevention, Youth, and Victim Services annually report to the General Assembly about opioid use disorder among incarcerated individuals in local correctional facilities by repealing c...
[Detail][Text][Discuss] | 2024-01-15
To Senate Judicial Proceedings Committee |
